Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.

Abstract

Adverse events were prevalent among MDR-TB cases treated in Latvia, with over two thirds requiring discontinuation of at least one drug. MDR-TB patients who are female, older or have severe TB disease should be closely monitored for treatment-related adverse events.